ABUS — ARBUTUS BIOPHARMA CORP
As of Q2 2026, 29 SEC-registered investment managers reported holding ABUS (ARBUTUS BIOPHARMA CORP) in their latest 13F filings, with a combined reported value of $248.18M across 51.84M shares. That is -6.7% by share count (-3.71M shares) versus the previous quarter, while reported value moved -0.5%. Ownership is concentrated: the five largest holders account for 80.7% of reported value and the top ten for 94.0%.
Compared with the prior quarter, 4 opened new positions, 19 added to existing stakes, 5 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ABUS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Morgan Stanley history | Q2 2026 | 17.70M | $84.95M | 0.01% | Reduce |
| BlackRock Inc history | Q2 2026 | 13.77M | $66.08M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 9.24M | $44.46M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 4.12M | $19.77M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 3.51M | $16.83M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 2.65M | $12.70M | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 2.47M | $11.84M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.43M | $6.87M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 1.42M | $6.81M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 879.24K | $4.22M | 0.00% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 650.70K | $3.12M | 0.00% | New |
| Millennium Management history | Q1 2026 | 642.45K | $2.89M | 0.00% | New |
| Wellington Management Group history | Q2 2026 | 461.65K | $2.22M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 454.12K | $2.18M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 404.70K | $1.94M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 381.86K | $1.83M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 267.19K | $1.28M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 250.91K | $1.20M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 249.21K | $1.20M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 170.45K | $818.18K | 0.00% | Add |
New Positions (Q2 2026)
- Arrowstreet Capital 650.70K sh · $3.12M
- JPMorgan Chase & Co 98.22K sh · $459.69K
- Two Sigma Investments 84.99K sh · $407.93K
- Lazard Asset Management 23.72K sh · $113.87K
Fully Exited (vs previous quarter)
- Millennium Management sold 642.45K sh · $2.89M
- Balyasny Asset Management sold 125.52K sh · $564.85K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | 221.18K | 239.01K | 197.18K | 218.95K | 212.01K | 241.89K | 4.88M | 5.08M | 5.26M | 6.98M | 8.83M | 20.96M | 21.71M | 22.59M | 23.79M | 24.16M | 24.45M | 26.70M | 25.89M | 17.70M |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 12.22M | 12.94M | 12.77M | 12.87M | 12.68M | 13.05M | 12.97M | 13.77M |
| Geode Capital Management | 1.54M | 1.67M | 1.73M | 1.79M | 2.01M | 2.13M | 2.29M | 2.60M | 2.70M | 2.82M | 2.96M | 3.31M | 3.45M | 3.48M | 3.54M | 3.64M | 3.67M | 3.68M | 3.77M | 4.12M |
| Goldman Sachs Group | 286.64K | 693.27K | 1.54M | 731.16K | 651.04K | 383.97K | 270.59K | 222.12K | 204.64K | 126.59K | 174.71K | 157.33K | 560.41K | 531.88K | 2.08M | 3.04M | 2.17M | 738.58K | 1.10M | 3.51M |
| Bank of America Corp | 1.89M | 1.21M | 47.76K | 38.46K | 55.18K | 74.28K | 87.98K | 111.52K | 90.76K | 91.95K | 68.46K | 83.28K | 189.40K | 361.30K | 458.23K | 1.20M | 1.45M | 1.83M | 1.68M | 2.65M |
| Legal & General Investment Management America | 6.53K | 6.53K | 7.95K | 10.47K | 12.20K | 12.20K | 12.20K | 14.06K | 12.31K | 12.31K | 12.31K | 15.25K | 145.80K | 118.69K | 118.40K | 124.49K | 124.18K | 122.76K | 2.40M | 2.47M |
| Charles Schwab Investment Management | 209.38K | 209.38K | 239.71K | 287.95K | 287.42K | 305.28K | 308.97K | 336.07K | 349.36K | 349.36K | 339.21K | 380.58K | 1.21M | 1.22M | 1.22M | 1.25M | 1.27M | 1.56M | 1.40M | 1.43M |
| Northern Trust Corp | 700.50K | 734.47K | 774.24K | 896.97K | 900.55K | 918.74K | 949.89K | 1.04M | 1.07M | 1.07M | 1.06M | 1.05M | 1.23M | 1.33M | 1.28M | 1.28M | 1.29M | 1.24M | 1.28M | 1.42M |
| Citigroup Inc | 14.68K | 24.65K | 30.99K | 9.60K | 3.43K | 2.77K | 285.28K | 550.06K | 527.66K | 879.68K | 696.89K | 1.71M | 743.85K | 487.72K | 821.64K | 884.61K | 1.48M | 1.57M | 1.33M | 879.24K |
| Arrowstreet Capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 159.12K | 35.12K | — | 650.70K |
| Wellington Management Group | — | 280.09K | 505.26K | 505.26K | 433.56K | 409.50K | 279.83K | — | — | — | 451.31K | 475.01K | 496.82K | 513.30K | 510.51K | 531.55K | 514.08K | 474.36K | 440.92K | 461.65K |
| BNY Mellon | 256.92K | 352.95K | 367.19K | 354.85K | 385.46K | 418.53K | 422.68K | 450.62K | 451.47K | 456.83K | 407.62K | 493.73K | 352.57K | 353.37K | 348.80K | 366.35K | 399.15K | 387.91K | 379.37K | 454.12K |
| Citadel Advisors | 1.06M | 950.85K | 826.98K | 361.25K | 457.96K | 667.06K | 398.54K | 2.43M | 2.14M | 2.07M | 2.20M | 198.47K | 697.74K | 360.06K | 214.91K | 227.77K | 277.09K | 149.34K | 785.24K | 404.70K |
| D. E. Shaw & Co | — | 22.90K | 19.70K | — | — | — | — | — | — | — | — | — | — | — | — | 40.70K | 189.95K | 231.76K | 143.20K | 381.86K |
| Fidelity Management & Research (FMR) | — | — | 164.13K | 163.31K | 186.78K | 185.21K | 186.72K | 184.91K | 176.14K | 165.34K | 165.84K | 100.82K | 83.28K | 77.91K | 78.01K | 80.74K | 89.46K | 136.56K | 145.13K | 267.19K |
| Invesco Ltd | 29.18K | 25.39K | 26.90K | 35.04K | 37.97K | 45.36K | 46.95K | 53.54K | 56.62K | 56.67K | 59.54K | 61.13K | 66.05K | 69.83K | 139.46K | 181.08K | 209.64K | 247.25K | 247.93K | 250.91K |
| UBS Group AG | — | 34.11K | 1.30K | — | — | 23.29K | 36.66K | 68.17K | 62.62K | 139.97K | 134.82K | 55.66K | 168.37K | 101.00K | 192.29K | 190.21K | 774.59K | 147.29K | 364.47K | 249.21K |
| Deutsche Bank AG | 46.22K | 48.80K | 43.55K | 56.76K | 49.54K | 50.26K | 71.96K | 55.51K | 69.35K | 66.54K | 72.86K | 72.80K | 96.55K | 171.77K | 146.86K | 113.71K | 131.82K | 140.20K | 160.74K | 170.45K |
| Wells Fargo & Co | 424.42K | 117.69K | 94.81K | 7.62K | 7.92K | 9.10K | 27.86K | 55.24K | 32.11K | 37.57K | 42.89K | 48.14K | 48.83K | 70.60K | 72.17K | 80.47K | 95.45K | 167.02K | 58.71K | 147.99K |
| JPMorgan Chase & Co | 37.61K | 42.74K | 58.93K | 64.19K | 69.73K | 72.84K | 207.13K | 105.06K | 119.00K | 115.48K | 88.13K | 80.73K | 89.59K | 896.26K | 538.63K | 86.08K | 98.23K | 97.88K | — | 98.22K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details